Synceptor, Inc.
- Biotech or pharma, therapeutic R&D
Synceptor, Inc. is a pioneering preclinical-stage biopharmaceutical company committed to developing transformative therapies for individuals affected by widespread metabolic disorders, including obesity, diabetes, non-alcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH).
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}